Rapid Detection of SARS-CoV-2 Virus Via Novel Direct Amplification Methods
Part # GPN058
Dana Brecklin1, Jennifer Mook1, Brad Hook1, PhD, Curtis Knox1, Terri McDonnell1, Rod Pennington1, PhD
1Promega Corporation, 2800 Woods Hollow Rd, Madison, WI 53711
The COVID-19 pandemic has challenged clinical labs to explore ways to increase testing capacity in response to unprecedented demand. This has created a global shortage of viral RNA extraction kits, necessitating the search for alternative methods to meet testing needs. Here, we describe a novel set of reagents and protocols to support rapid viral testing via direct amplification without the need for viral RNA extraction.
Printed in USA.